Andreas Thimm
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen - a multicenter observational study.
Journal: Orphanet journal of rare diseases
Published: February 23, 2025
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival.
Journal: Annals of hematology
Published: January 17, 2025
Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survival.
Journal: Haematologica
Published: April 10, 2023
Corneal confocal microscopy reveals small nerve fibre loss correlating with motor function in adult spinal muscular atrophy.
Journal: European journal of neurology
Published: March 10, 2023
Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis.
Journal: Journal of neurology
Published: January 10, 2023
Total Plasma Exchange in Neuromuscular Junction Disorders-A Single-Center, Retrospective Analysis of the Efficacy, Safety and Potential Diagnostic Properties in Doubtful Diagnosis.
Journal: Journal of clinical medicine
Published: June 30, 2022
Prevalence and predictors of neurological manifestations in systemic AL amyloidosis.
Journal: Journal of the neurological sciences
Published: March 07, 2022
Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosis.
Journal: Annals of clinical and translational neurology
Published: February 10, 2022
A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case report.
Journal: BMC neurology
Published: December 15, 2021
Last Updated: 09/26/2026